Pleiotropic effects of insulin and GLP-1 receptor agonists: Potential benefits of the association
Author:
Publisher
Elsevier BV
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference91 articles.
1. Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making;Scholz;Ther Adv Endocrinol Metab,2014
2. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and European Association for the Study of Diabetes;Inzucchi;Diabetologia,2015
3. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes;Morrish;Diabetologia,2001
4. Pharmacology, physiology, and mechanisms of incretin hormone action;Campbell;Cell Metab,2013
5. The effect of glucagonlike peptide 1 on cardiovascular risk;Sivertsen;Nat Rev Cardiol,2012
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GLP-1R agonist liraglutide attenuates pain hypersensitivity by stimulating IL-10 release in a nitroglycerin-induced chronic migraine mouse model;Neuroscience Letters;2023-08
2. Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease;International Journal of Molecular Sciences;2023-05-26
3. Current and emerging drugs for the treatment of atherosclerosis: the evidence to date;Expert Review of Cardiovascular Therapy;2022-07-03
4. Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira);Diabetes Therapy;2020-10-26
5. Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update;Diabetes Therapy;2020-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3